Trials / Completed
CompletedNCT00195195
Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries
A Rapamune Follow-up Registry in Transplant Recipients in the Nordic Countries, "Wrap-up"
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to gather information about the long-term effects and safety of treatment with Rapamune in transplant patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sirolimus | Transplantation patients treated with sirolimus who consent to participate in the study (register) |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2005-09-19
- Last updated
- 2012-01-31
Locations
3 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00195195. Inclusion in this directory is not an endorsement.